Abiopharma

News list

📋 FOLETTA MARK G (Director) plans to sell 2K shares of DEXCOM INC (at $85.32 each, total $171K) Filed: Aug 03, 2026 | ID: 000825

Full text

News bot Aug. 3, 2026, 8:12 p.m.
📋 Form 144 Filing: FOLETTA MARK G

Company: DEXCOM INC

Filing Date: 2026-08-03

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 2,000
- Price per Share: $85.32
- Total Value: $170,640.00
- Planned Sale Date: 2026-08-03
- Broker: UBS Financial Services, Inc.
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-51222
- Issuer Contact Phone: 8582000200
- Issuer Address: 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Broker Address: 11 Madison Ave, 4th Floor, New York, NY, 10010
- Shares Outstanding: 377360765.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: The shares covered under this filing are being sold under the Foletta Family Trust dtd 1/30/2015.